Xaira Therapeutics

Xaira TherapeuticsXaira Therapeutics
Xaira Therapeutics

Xaira Therapeutics

AI-powered biotech platform using protein design to discover novel therapeutic molecules for hard-to-treat targets.

Website
2024Active
Rate
Advertise here

About

Xaira Therapeutics is an AI-powered biotechnology company pioneering transformative artificial intelligence to discover and develop next-generation medicines. Their core product, X-Cell, is a virtual cell model and the largest causal perturbation model built to date, designed to accurately predict the outcomes of genetic perturbations. This technology aims to transform drug discovery into a predictive engineering discipline, ultimately delivering a pipeline of new medicines to patients.

Technology stack

detected 2026-07-05
CDN
Cloudflare
EmailGoogle Workspace
Stack
Webflow
Cookie consent
OneTrust
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Xaira Therapeutics do?

Xaira Therapeutics is an AI-powered biotechnology company pioneering transformative artificial intelligence to discover and develop next-generation medicines. Their core product, X-Cell, is a virtual cell model and the largest causal perturbation model built to date, designed to accurately predict the outcomes of genetic perturbations. This technology aims to transform drug discovery into a predictive engineering discipline, ultimately delivering a pipeline of new medicines to patients.

Where is Xaira Therapeutics headquartered?

Xaira Therapeutics is headquartered in San Francisco, United States.

When was Xaira Therapeutics founded?

Xaira Therapeutics was founded in 2024.

What industry does Xaira Therapeutics operate in?

Xaira Therapeutics operates in Biotech, Drug Discovery, AI-Driven Protein Design, Genomics, MedTech, AI Infrastructure.

What is Xaira Therapeutics's valuation?

StartupHub estimates Xaira Therapeutics's effective valuation at $2.8B (range $2.0B to $3.7B, 41% confidence), based on comparable companies in the sector.